Article
Insights into the variability of nasal potential difference, a biomarker of CFTR activity.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Jul 2020
Kyrilli Spyridoula, Henry Theophraste, Wilschanski Michael, Fajac Isabelle, Davies Jane C, Jais Jean-Philippe, Sermet-Gaudelus Isabelle
Abstract excerpt
BACKGROUND: Nasal potential difference (NPD) is used to evaluate CFTR function in vivo. We aimed to evaluate the intrasubject and intersubject variability of NPD measurements. METHODS: We reviewed NPD tracings of 116 patients with CF enrolled in the placebo arm of a multicenter study. Patients carried at least one nonsense mutation and underwent repeated NPD tests every 16 weeks. NPD parameters included basal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
